美国的结核病：2013 - 2017年5个结核病区域培训与医学咨询中心提供的医学咨询服务
Tuberculosis in the United States: Medical Consultation Services Provided by 5 Tuberculosis Regional Training and Medical Consultation Centers, 2013-2017.
作者信息
Goswami Neela D, Mase Sundari, Griffith David, Bhavaraju Rajita, Lardizabal Alfred, Lauzardo Michael, Chen Lisa, Wilson John, Chappelle Courtney, Haley Connie A
机构信息
US Centers for Disease Control and Prevention, Atlanta, Georgia.
World Health Organization, India-WHO Country Office, Delhi, India.
出版信息
Open Forum Infect Dis. 2019 Apr 4;6(6):ofz167. doi: 10.1093/ofid/ofz167. eCollection 2019 Jun.
Abstract
With only 9105 new US tuberculosis (TB) cases reported in 2017, expert consultation is essential for TB care. Data were captured 2013-2017 from consultations by 5 CDC-funded centers, now the TB Centers of Excellence (COEs). 14 586 consultations were provided to TB providers, most related to TB disease and treatment regimens.
摘要
2017年美国仅报告了9105例新发结核病病例，因此专家会诊对于结核病治疗至关重要。数据收集于2013年至2017年期间，来自5个由美国疾病控制与预防中心资助的中心（现称为结核病卓越中心）的会诊。共为结核病医疗服务提供者提供了14586次会诊，其中大部分与结核病疾病及治疗方案有关。
相似文献
1
Tuberculosis in the United States: Medical Consultation Services Provided by 5 Tuberculosis Regional Training and Medical Consultation Centers, 2013-2017.
Open Forum Infect Dis. 2019 Apr 4;6(6):ofz167. doi: 10.1093/ofid/ofz167. eCollection 2019 Jun.
2
A model for bringing TB expertise to HIV providers: Medical consultations to the CDC-funded Regional Tuberculosis Training and Medical Consultation Centers, 2013-2017.
PLoS One. 2020 Aug 31;15(8):e0236933. doi: 10.1371/journal.pone.0236933. eCollection 2020.
3
Tuberculosis Regional Training and Medical Consultation Centers in the United States: Characteristics, outcomes, and quality of medical consultations, June 1, 2010 - May 31, 2014.
J Clin Tuberc Other Mycobact Dis. 2019 Jul 2;17:100114. doi: 10.1016/j.jctube.2019.100114. eCollection 2019 Dec.
4
Pediatric tuberculosis consultations across 5 CDC regional tuberculosis training and medical consultation Centers.
J Clin Tuberc Other Mycobact Dis. 2018 Apr 11;11:23-27. doi: 10.1016/j.jctube.2018.04.004. eCollection 2018 May.
5
Challenges in LTBI care in the United States identified using a nationwide TB medical consultation database.
Public Health Action. 2021 Sep 21;11(3):162-166. doi: 10.5588/pha.21.0026.
6
Analysis of panel physician inquiries to U.S. TB Centers of Excellence, 2018-2022.
IJTLD Open. 2024 Nov 1;1(11):490-494. doi: 10.5588/ijtldopen.24.0056. eCollection 2024 Nov.
7
Linezolid use for the treatment of multidrug-resistant tuberculosis, TB centers of excellence, United States, 2013-2018.
J Clin Tuberc Other Mycobact Dis. 2020 Nov 16;22:100201. doi: 10.1016/j.jctube.2020.100201. eCollection 2021 Feb.
8
Multidrug-resistant tuberculosis care in the United States.
Int J Tuberc Lung Dis. 2020 Apr 1;24(4):409-413. doi: 10.5588/ijtld.19.0515.
9
[Medical service systems for tuberculosis in low-incidence countries].
Kekkaku. 2012 Sep;87(9):577-84.
10
Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005.
MMWR Recomm Rep. 2005 Dec 30;54(RR-17):1-141.
引用本文的文献
1
Challenges in LTBI care in the United States identified using a nationwide TB medical consultation database.
Public Health Action. 2021 Sep 21;11(3):162-166. doi: 10.5588/pha.21.0026.
2
Linezolid use for the treatment of multidrug-resistant tuberculosis, TB centers of excellence, United States, 2013-2018.
J Clin Tuberc Other Mycobact Dis. 2020 Nov 16;22:100201. doi: 10.1016/j.jctube.2020.100201. eCollection 2021 Feb.
3
A model for bringing TB expertise to HIV providers: Medical consultations to the CDC-funded Regional Tuberculosis Training and Medical Consultation Centers, 2013-2017.
PLoS One. 2020 Aug 31;15(8):e0236933. doi: 10.1371/journal.pone.0236933. eCollection 2020.
4
The War against Tuberculosis: A Review of Natural Compounds and Their Derivatives.
Molecules. 2020 Jun 30;25(13):3011. doi: 10.3390/molecules25133011.
5
Multidrug-resistant tuberculosis care in the United States.
Int J Tuberc Lung Dis. 2020 Apr 1;24(4):409-413. doi: 10.5588/ijtld.19.0515.
6
Multidrug-Resistant Tuberculosis in Patients with Human Immunodeficiency Virus. Management Considerations within High-resourced Settings.
Ann Am Thorac Soc. 2020 Jan;17(1):16-23. doi: 10.1513/AnnalsATS.201902-185CME.
本文引用的文献
1
The California Multidrug-Resistant Tuberculosis Consult Service: a partnership of state and local programs.
Public Health Action. 2018 Mar 21;8(1):7-13. doi: 10.5588/pha.17.0091.
2
Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children.
Clin Infect Dis. 2017 Jan 15;64(2):111-115. doi: 10.1093/cid/ciw778.
3
Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.
Clin Infect Dis. 2016 Oct 1;63(7):e147-e195. doi: 10.1093/cid/ciw376. Epub 2016 Aug 10.
4
Provisional CDC guidelines for the use and safety monitoring of bedaquiline fumarate (Sirturo) for the treatment of multidrug-resistant tuberculosis.
MMWR Recomm Rep. 2013 Oct 25;62(RR-09):1-12.
5
Supporting TB clinicians managing difficult cases: the ERS/WHO Consilium.
Eur Respir J. 2013 Mar;41(3):491-4. doi: 10.1183/09031936.00196712.
Zotero 插件